| Bioactivity | ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 also has immunomodulating activity, and can be used in research of autoimmune diseases[1]. |
| Target | S1P1 receptor. |
| Name | ACT-209905 |
| CAS | 1062670-13-6 |
| Formula | C26H35N5O5 |
| Molar Mass | 497.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bien-Möller S, et al. The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro. Cancers (Basel). 2023 Aug 26;15(17):4273. |
ACT-209905
CAS: 1062670-13-6 F: C26H35N5O5 W: 497.59
ACT-209905 is a S1P1 receptor agonist. ACT-209905 can inhibit glioblastoma (GBM) cell growth and migration. ACT-209905 a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.